News - Applied StemCell

Applied StemCell Strengthens Executive Leadership with Two Key Appointments

December 04, 2023 9:00 AM PST MILPITAS, Calif.–Applied StemCell, Inc., a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy

New Breakthrough in Cell Transplantation Therapy: Applied StemCell’s Patent for HLA-Engineered Universal Donor Cells Approved

October 01, 2024 10:00 AM PST MILPITAS, Calif. – Applied StemCell, Inc. is proud to announce the successful approval of its latest U.S. patent which covers HLA-F engineered universal